By
World Health Organization
Published: Sept. 22, 2023, 4:37 p.m.·
Tags:
Global TB response,
Advocacy
World leaders at the UN High-Level Meeting on TB have approved a Political Declaration with ambitious new targets for the next five years to advance the global efforts towards ending the TB epidemic.
Read More →
By
USAID
Published: Sept. 22, 2023, 12:33 p.m.·
Tags:
Prevention,
Access
USAID and PEPFAR announce that they have secured a 30% price reduction on the TB preventive treatment regimen called 3HP, taking the price from $14.25 to $9.99 for a three-month patient course.
Read More →
By
TB advocates
Published: Sept. 22, 2023, 7:40 a.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Ukraine, Belarus, Azerbaijan and Moldova demand that Johnson & Johnson take urgent action to improve equitable access to bedaquiline in all countries with a high burden of TB.
Read More →
By
Treatment Action Group
Published: Sept. 20, 2023, 4:20 p.m.·
Tags:
Global TB response,
Research and development,
Advocacy
A sobering new analysis from Treatment Action Group shows that governments failed to meet previous commitments to fund TB research.
Read More →
By
1/4/6x24 Campaign Coalition,
Treatment Action Group
Published: Sept. 19, 2023, 7:25 p.m.·
Tags:
Treatment,
Access,
Advocacy
Ahead of the UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign is sounding the alarm that the political declaration commits neither the funding nor the actions needed to expand access to the best-available TB regimens and diagnostics.
Read More →
By
Global Fund to Fight AIDS, Tuberculosis and Malaria,
Stop TB Partnership,
USAID
Published: Sept. 19, 2023, 5:10 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.
Read More →
By
Global Fund to Fight AIDS, Tuberculosis and Malaria
Published: Sept. 18, 2023, 1 p.m.·
Tags:
Global health,
Global TB response
Results in the fight against HIV, TB and malaria exceed pre-COVID-19 numbers; yet colliding crises keep the world way off track to achieve 2030 targets.
Read More →
By
University of California, San Francisco
Published: Sept. 13, 2023, 1:26 p.m.·
Tags:
Global TB response,
Advocacy
Without action, more than 27 million lives could be lost between now and 2050.
Read More →
By
Médecins Sans Frontières
Published: Sept. 12, 2023, 1:47 p.m.·
Tags:
Global TB response,
Access,
Advocacy
TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools.
Read More →
By
World Health Organization
Published: Sept. 12, 2023, 12:58 p.m.·
Tags:
Global health,
Public health,
Global TB response,
Advocacy
WHO urges world leaders to commit to progress on pandemic prevention, preparedness and response and to secure health for all, end TB, and reinvigorate SDGs.
Read More →
Page 1 of 126 · Total posts: 10
1
2
Last→